OQS
GRTX

Occudo Quantitative Strategies’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Occudo Quantitative Strategies’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-30,442
Closed -$72K – 1441
2022
Q1 		$72K Buy
+30,442
New +$79.3K 0.01% 1048

Other funds holding GRTX

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Occudo Quantitative Strategies's GRTX Position: Q2 2022 in Review

Occudo Quantitative Strategies sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2022, closing a stake of 30,442 shares — an estimated $72K sold.

Occudo Quantitative Strategies first reported a position in GRTX in Q1 2022 and held it in 1 quarter. The position peaked at $72K in Q1 2022. 39 funds tracked by Wall St. Rank hold GRTX as of Q2 2022.

  • Occudo Quantitative Strategies reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 30,442 Galera Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $72K.
  • Occudo Quantitative Strategies first reported a position in Galera Therapeutics, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Galera Therapeutics, Inc. Common Stock position peaked at $72K in Q1 2022.
  • 39 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.